logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Calcitonin Gene-related Peptide Receptor Antagonist class drugs

    FiltersReset Filters
    5 results

    • nurtec odt

      (rimegepant sulfate)
      Pfizer Laboratories Div Pfizer Inc
      Usage: NURTEC ODT is indicated for the acute treatment of migraine with or without aura, as well as for the preventive treatment of episodic migraine in adults.

    • qulipta

      (Atogepant)
      AbbVie Inc.
      Usage: QULIPTA is indicated for the preventive treatment of migraine in adults.

    • ubrelvy

      (ubrogepant)
      Allergan, Inc.
      Usage: UBRELVY is indicated for the acute treatment of migraine with or without aura in adults. It is not intended for the preventive treatment of migraine.

    • zavzpret

      (zavegepant)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ZAVZPRET is indicated for the acute treatment of migraine in adults, with or without aura. It is not intended for the preventive treatment of migraine.

    • zavzpret

      (zavegepant)
      U.S. Pharmaceuticals
      Usage: ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults. It is not approved for the preventive treatment of migraine.